Abstract:How to tune the structure of nanocarriers with fast acidic-degradation rate and high stability in physiological condition or during storage is also an intrinsic limitation. In this context, a kind of dual-pH responsive micelles with well-balanced stability, that is, fast hydrolysis in an acidic environment and impediment of the blood drug release with high stability at 7.4 were developed, i.e. the self-assembly micelles of poly(ethylene glycol)-b-(poly ε-caprolactone-gpoly(2,2-dimethyl-1,3-dioxolane-4-yl) methylacrylate-co-2 (dimethylamino) ethyl methacrylate) (mPEG-b-(PCL-g-P(DA-co-DMAEMA))) copolymers with two inert pH responsive moieties of DA and DMAEMA. The fast synergistic acid-triggered disassembly and high stability at physiological condition of the mPEG-b-(PCL-g-P(DA-co-DMAEMA)) micelles was certificated by 1 H-NMR, particle size and optical stability measurements, which was induced and mediated by the synergistic pH responses of the hydrolysis of the ketal in DA moieties and the switch in solubility of tertiary amino moieties (DMAEMA) at mild acid condition. It was observed that the hydrolysis rate of the ketal could be promoted by increasing the contents of DMAEMA moieties. The fast intracellular disassembly of the micelles depending on the contents of DMAEMA moieties was also traced by fluorescence resonance energy transfer (FRET). The in vitro release studies showed that the release of DOX from mPEG-b-(PCL-g-P(DA-co-DMAEMA)) micelles at mild acid condition was significantly accelerated by increasing the contents of DMAEMA moieties, while greatly impeded the drug release in the physiological conditions. The antitumor activity of DOXloaded micelles was studied in MCF-7 and 4T1 cells in vitro and in 4T1 tumor-bearing Balb-c mice in vivo. The results indicated the DOX-loaded micelles with higher content of DMAEMA moieties exhibited enhanced anti-cancer activity. Collectively, the synergistic dual-pH responsive design of mPEG-b-(PCL-g-P(DA-co-DMAEMA)) micelles provided a new operably for improving anticancer drug delivery efficiency.

Self-Assembled Micelles Of Peg-Poly(Disulfide Carbamate Amine) Copolymers For Intracellular Dual-Responsive Drug Delivery

Light And Ph Dual-Degradable Triblock Copolymer Micelles For Controlled Intracellular Drug Release

Synergistic Dual-pH Responsive Copolymer Micelles for Impediment of the Blood Drug Release and Motivation of the Intracellular

PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.

Polyaspartamide-based multi-responsive micelle with sheddable shell for antitumor drug delivery

Design and Synthesis of Redox and Oxidative Dual Responsive Block Copolymer Micelles for Intracellular Drug Delivery

Ph-Responsive Polymeric Micelles Based on Poly(ethyleneglycol)-B-poly(2-(diisopropylamino) Ethyl Methacrylate) Block Copolymer for Enhanced Intracellular Release of Anticancer Drugs.

New Liquid Crystal Polycarbonate Micelles for Intracellular Delivery of Anticancer Drugs

Dual‐responsive polycarbonate micelles for activating intracellular drug release

Drug Self-Assembled Delivery System with Dual Responsiveness for Cancer Chemotherapy

Dual‐responsive Crosslinked Micelles of a Multifunctional Graft Copolymer for Drug Delivery Applications

Redox and Ph-Responsive Poly (amidoamine) Dendrimer–poly (ethylene Glycol) Conjugates with Disulfide Linkages for Efficient Intracellular Drug Release

Synthesis and physicochemical properties of doxorubicin-loaded PEGA containing amphiphilic block polymeric micelles

PDEAEMA-based pH-sensitive amphiphilic pentablock copolymers for controlled anticancer drug delivery

Redox-responsive Micelles Self-Assembled from Dynamic Covalent Block Copolymers for Intracellular Drug Delivery.

Biodegradable Micelles Based on Poly(Ethylene Glycol)-B-Polylipopeptide Copolymer: A Robust and Versatile Nanoplatform for Anticancer Drug Delivery

Reduction-sensitive Micelles with Sheddable PEG Shells Self-Assembled from a Y-shaped Amphiphilic Polymer for Intracellular Doxorubicine Release.

Biocompatible And Bioreducible Micelles Fabricated From Novel Alpha-Amino Acid-Based Poly(Disulfide Urethane)S: Design, Synthesis And Triggered Doxorubicin Release

Polymeric Micelles Based on PEGylated Chitosan-G-lipoic Acid As Carrier for Efficient Intracellular Drug Delivery.

Fabrication of Dual-Sensitive Poly(β-Hydroxyl Amine) Micelles for Controlled Drug Delivery

Ph- And Beta-Cyclodextrin-Responsive Micelles Based On Polyaspartamide Derivatives As Drug Carrier